Eli Lilly director Jamere Jackson gets 168-share grant
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eli Lilly & Co. (LLY) director Jamere Jackson received a grant/award of 168 shares of common stock on November 16, 2026. His reported directly held position after the transaction was 9,861 shares. The transaction was an award acquisition, not a market purchase.
Insider Trade Summary
Grant/Award: 167.6364 shares
Grant/Award
1 txn
Insider
JACKSON JAMERE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 167.6364 | $1,431.67 | $240K |
Holdings After Transaction:
Common Stock — 9,861.2537 shares (Direct)
Holdings Before and After:
Common Stock, 9,693.6173 to 9,861.2537 shares (Direct)
Key Figures
Award shares: 168 shares
Directly held shares after transaction: 9,861 shares
2 metrics
Award shares
168 shares
Grant/award acquisition on November 16, 2026
Directly held shares after transaction
9,861 shares
Reported position after the transaction
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.